Mac was specifically named in the Class Action, along with Radient the Company. That alone is reason enough to see the Class Action finished before dumping the company.
Wolfie and DC keep talking about Unipharma, Pharmigene, and Arima. I don't think they realize that they own no stock in those companies. They own RXPC stock and RXPC stock is worthless.
The "patents" that Wolfie hoowls about haven't even been applied for yet by Unipharma. Uni claims they are developing a second generation of DR-70 and they will protect that new formulation with patents, but I doubt that will ever happen -- Radient tried to find a replacement for HRP for years and failed.
Regardless -- anything Uni does won't benefit RXPC shareholders.
News 
Market Data 
Discover 
